I can summarize what the medical research generally says, but first a quick safety note: Lyrica (pregabalin) is not an antidepressant, though it can be used for conditions that commonly co-occur with depression (especially anxiety and neuropathic pain). “Combining antidepressants with Lyrica” is mostly studied/used as adjunct therapy for depression/anxiety symptoms and/or for pain-related depression, rather than as a single standardized depression regimen.
What the latest evidence generally looks like (2020s)
1) For anxiety disorders (often used with SSRIs/SNRIs)
- Pregabalin has evidence for generalized anxiety disorder (GAD), and in practice it’s sometimes used alongside an SSRI/SNRI.
- Trials and reviews in the last several years generally support that adding pregabalin can improve anxiety symptoms in some patients, particularly early on.
- However, antidepressants (SSRIs/SNRIs) often take weeks to work, while pregabalin may act faster, so clinicians may use it as an adjunct early.
Bottom line: The strongest/most consistent “combo” evidence tends to be for anxiety, not classic depression alone.
2) For depression with comorbid pain (neuropathic pain → depressive symptoms)
- There’s also a research thread examining pregabalin for chronic neuropathic pain, where pain relief can indirectly improve mood and quality of life.
- When studies examine depression outcomes, they often show improvements that may track with pain improvement rather than a direct antidepressant effect.
Bottom line: Combo rationale here is usually pain + mood, where treating pain reduces depressive burden.
3) Direct evidence for antidepressant + pregabalin specifically for major depressive disorder
- Compared with SSRIs/SNRIs augmentation strategies (e.g., atypical antipsychotics, lithium, mirtazapine, thyroid hormone), direct high-quality evidence for pregabalin as an antidepressant augmenting agent is relatively limited.
- Most “latest” literature and guidelines emphasize pregabalin for anxiety and neuropathic pain, with less robust evidence for primary depression augmentation.
Bottom line: It’s not considered a top-tier evidence-based augmentation strategy for major depression in the way some other agents are.
Safety/interaction findings (important with combos)
Across reviews and clinical experience, the main concerns when combining with antidepressants are usually additive side effects, not a specific dangerous drug–drug interaction:
- Sedation / dizziness / impairment: antidepressants (especially some) + pregabalin can increase drowsiness and affect driving.
- Weight gain: pregabalin can cause weight gain in some patients; several antidepressants can too.
- Cognitive slowing: sometimes more noticeable with the combination.
- Respiratory depression risk (uncommon, but serious) especially if combined with other CNS depressants (opioids, benzodiazepines, alcohol).
- Serotonin syndrome: pregabalin doesn’t usually increase serotonin, so serotonin syndrome is not a typical concern with pregabalin + SSRIs/SNRIs.
What clinicians often do (real-world practice pattern)
- Start an antidepressant (SSRI/SNRI) and consider pregabalin for prominent anxiety, sleep disruption, or pain-related symptoms.
- Use the lowest effective pregabalin dose and reassess frequently—some clinicians taper off pregabalin after the antidepressant becomes effective.
If you tell me these 4 details, I can be much more specific
- Which antidepressant (sertraline, escitalopram, venlafaxine, duloxetine, bupropion, etc.)?
- What condition is being treated: GAD, panic, MDD, PTSD, depression with pain, etc.?
- Current doses and how long you’ve been on each?
- Any other meds/substances (especially opioids, benzodiazepines, alcohol)?
Quick questions back (so I can give the “latest research” that matches your situation)
Are you asking about combining pregabalin with an SSRI/SNRI for anxiety, or with an antidepressant for major depressive disorder specifically? And which antidepressant are you referring to?